{
  "pmcid": "11724455",
  "sha256": "702a809c0f1dba69f23a04623f0faab558c2f572dc9467f4a93e358284530f40",
  "timestamp_utc": "2025-11-09T22:06:54.278507+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 12.43404081632653,
    "reading_ease": 23.371673469387787,
    "word_count": 196
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Preoperative Smoking Cessation Interventions"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "This systematic review included randomised controlled trials (RCTs) and non-RCTs."
      },
      "Participants": {
        "score": 2,
        "evidence": "Participants were smokers aged over 18 scheduled for elective surgery."
      },
      "Intervention": {
        "score": 2,
        "evidence": "The intervention group received preoperative smoking cessation support, while the control group received usual care."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study evaluates the effectiveness of preoperative smoking cessation interventions."
      },
      "Method_Outcome": {
        "score": 1,
        "evidence": "The primary outcome was smoking cessation at surgery time and at the last follow-up."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Randomisation and allocation concealment methods were not specified."
      },
      "Blinding": {
        "score": 0,
        "evidence": "Blinding details were not provided."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "Sixteen studies (3505 participants) were included, with 14 RCTs (2940 participants) in the meta-analysis."
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The intervention group had significantly increased odds of quitting smoking at surgery time (RR 1.64, 95% CI 1.30–2.07) and at the longest follow-up (RR 1.38, 95% CI 1.12–1.70)."
      },
      "Harms": {
        "score": 0,
        "evidence": "Adverse events were not reported."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: PROSPERO CRD42023423202."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified."
      }
    },
    "total_score": 13,
    "max_score": 25
  }
}